Presenter: Dr. Tina Korownyk G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD
In episode 483, James and Mike invite Tina to the podcast to talk about the aducanumab (Aduhelm) FDA approval story. We look at all the latest evidence, we talk about how people analyzed the data, whether or not the findings were clinically important, the side effects and finally the cost. And no matter how we…
CFP Podcast: Cognitive behavioural therapy for insomnia
CFP Podcast: Thoughtful prescribing for patients with difficult-to-treat depression
CFP Podcast: Screening for primary prevention of fragility fractures: how much time does it take?
Presenter(s):
Dr. Tina Korownyk G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD
Please provide any additional comments (optional).